{{medical}}
{{noteTA
|T=zh-hans:; zh-hant:馬凡氏症候群;
|G1=Medicine
|1=zh-hans:综合征; zh-hant:症候群;
|2=zh-hans:症状;zh-hant:病徵;
}}
{{Infobox disease
| Name = 馬凡氏症候群<br />{{lang|en|Marfan syndrome}}
| Image = Myxomatous aortic valve.jpg
| Caption = [[顯微照片|顯微照片]]演示[[黏液變性|黏液變性]]的[[主動脈瓣|主動脈瓣]]，一個馬凡氏症候群的的共同表現。
| DiseasesDB = 7845
| ICD10 = {{ICD10|Q|87|4|q|80}}
| ICD9 = {{ICD9|759.82}}
| ICDO =
| OMIM = 154700
| MedlinePlus = 000418
| eMedicineSubj = ped
| eMedicineTopic = 1372
| eMedicine_mult = {{eMedicine2|orthoped|414}}
| MeshID = D008382
| GeneReviewsNBK = NBK1335
| GeneReviewsName = Marfan Syndrome
}}

<!-- Definition and symptoms -->
'''馬凡氏症候群'''（{{lang-en|Marfan syndrome}}，簡稱為 '''MFS'''），是一種{{le|遺傳性|genetic disorder|遺傳性疾病}}的[[結締組織|結締組織]]疾病，會有多處病灶，嚴重程度會因人而異<ref>{{cite journal | vauthors = Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM | display-authors = 6 | title = The revised Ghent nosology for the Marfan syndrome | journal = Journal of Medical Genetics | volume = 47 | issue = 7 | pages = 476–485 | date = July 2010 | pmid = 20591885 | doi = 10.1136/jmg.2009.072785 | s2cid = 13895128 | hdl = 1854/LU-1013955 }}</ref><ref>{{cite journal | vauthors = Nistri S, De Cario R, Sticchi E, Spaziani G, Della Monica M, Giglio S, Favilli S, Giusti B, Stefano P, Pepe G | display-authors = 6 | title = Differential Diagnosis between Marfan Syndrome and Loeys-Dietz Syndrome Type 4: A Novel Chromosomal Deletion Covering TGFB2 | journal = Genes | volume = 12 | issue = 10 | pages = 1462 | date = September 2021 | pmid = 34680857 | pmc = 8536070 | doi = 10.3390/genes12101462 | doi-access = free }}</ref><ref name="NIH2010What">{{cite web|title=What Is Marfan Syndrome? |url=https://www.nhlbi.nih.gov/health/health-topics/topics/mar#|website=NHLBI, NIH|access-date=16 May 2016|date=October 1, 2010 |url-status=live |archive-url=https://web.archive.org/web/20160506150850/http://www.nhlbi.nih.gov/health/health-topics/topics/mar|archive-date=6 May 2016}}</ref>。患者通常身材高瘦，手腳、手指和腳趾修長，有[[蜘蛛樣指|蜘蛛樣指]]<ref name=NIH2010What/>。他們往往也會有{{le|關節過動|Hypermobility (joints)|關節活動範圍過大}}和[[脊椎側彎|脊椎側彎]]<ref name=NIH2010What/>。最嚴重的併發症會進犯[[心臟|心臟]]和[[主動脈|主動脈]]，罹患{{le|二尖瓣脫垂|mitral valve prolapse}}和[[主動脈瘤|主動脈瘤]]的風險較高<ref name=NIH2010What/><ref>{{cite web|title=What Are the Signs and Symptoms of Marfan Syndrome? |url=https://www.nhlbi.nih.gov/health/health-topics/topics/mar/signs|website=NHLBI, NIH|access-date=16 May 2016|date=October 1, 2010 |url-status=live |archive-url=https://web.archive.org/web/20160611000255/https://www.nhlbi.nih.gov/health/health-topics/topics/mar/signs|archive-date=11 June 2016}}</ref>，其他常見的進犯部位還有[[肺|肺]]部、[[眼|眼]]部、[[骨骼|骨骼]]和[[硬腦膜|硬腦膜]]<ref name=NIH2010What/>。

<!-- Cause, mechanism, and diagnosis -->
此症為[[顯性|顯性]]疾患<ref name=NIH2010What/>，肇因於{{le|第15對染色體上的纖維蛋白 FBN1|Fibrillin 1}}發生變異，其為製造{{le|小纖維蛋白|Fibrillin}}的基因，導致結締組織不正常<ref name=NIH2010What/>。有七成五的患者是透過父母遺傳罹病，兩成五則是源自於偶發性突變<ref name=NIH2010What/>。診斷需基於{{le|根特診斷標準|Ghent criteria}}<ref name="NIH2010Diag">{{cite web|title=How Is Marfan Syndrome Diagnosed?|url=https://www.nhlbi.nih.gov/health/health-topics/topics/mar/diagnosis|website=NHLBI, NIH|access-date=16 May 2016|date=October 1, 2010|url-status=live|archive-url=https://web.archive.org/web/20160611015839/https://www.nhlbi.nih.gov/health/health-topics/topics/mar/diagnosis|archive-date=11 June 2016}}</ref><ref name="NORD2017">{{cite web|date=2017|title=Marfan Syndrome|url=http://rarediseases.org/rare-diseases/marfan-syndrome/|access-date=5 November 2016|website=National Organization for Rare Disorders|archive-date=2019-11-12|archive-url=https://web.archive.org/web/20191112111640/https://rarediseases.org/rare-diseases/marfan-syndrome/|dead-url=no}}</ref>。

<!-- Prevention and treatment  -->
馬凡氏症候群無法治癒<ref name=NIH2010What/>，但只要接受適當的治療，許多患者的壽命與一般[[預期壽命|平均壽命]]無異<ref name=NIH2010What/>。該症候群通常使用[[β受體阻滯劑|β受體阻滯劑]]控制病情，像是[[普萘洛爾|普萘洛爾]]或[[阿替洛爾|阿替洛爾]]等藥物；如果患者無法耐受，則會改用[[鈣離子通道阻滯劑|鈣離子通道阻滯劑]]或[[血管張力素I型轉化酶抑制劑|血管張力素I型轉化酶抑制劑]]<ref name=NORD2017/><ref name=NIH2010Tx/>。建議患者避免劇烈運動<ref name=NORD2017/>，如果必要，患者可能需接受手術修復主動脈或置換[[心瓣|瓣膜]]<ref name="NIH2010Tx">{{cite web|title=How Is Marfan Syndrome Treated?|url=https://www.nhlbi.nih.gov/health/health-topics/topics/mar/treatment|website=NHLBI, NIH|access-date=16 May 2016|date=October 1, 2010|url-status=live|archive-url=https://web.archive.org/web/20160611003149/https://www.nhlbi.nih.gov/health/health-topics/topics/mar/treatment|archive-date=11 June 2016}}</ref>。

<!-- Epidemiology -->
馬凡氏症候群患者大約在5,000到10,000人中就有一位<ref name=NORD2017/><ref name="PMID18506019">{{cite journal | vauthors = Keane MG, Pyeritz RE | title = Medical management of Marfan syndrome | journal = Circulation | volume = 117 | issue = 21 | pages = 2802–2813 | date = May 2008 | pmid = 18506019 | doi = 10.1161/CIRCULATIONAHA.107.693523 | quote = estimated prevalence of 1 case per 3000 to 5000 individuals | doi-access = free }}</ref>，患病機率在世界不同地區中並無差異<ref name=PMID18506019/>。此症的命名由來是一位[[法國|法國]][[小兒科|小兒科]]醫師{{le|安東尼·馬凡|Antoine Marfan}}，他在1896年留下了此症的第一份記敘<ref name="Marfan1896">{{cite journal|author=Marfan, Antoine|year=1896|title=Un cas de déformation congénitale des quartre membres, plus prononcée aux extrémitiés, caractérisée par l'allongement des os avec un certain degré d'amincissement [A case of congenital deformation of the four limbs, more pronounced at the extremities, characterized by elongation of the bones with some degree of thinning]|journal=Bulletins et Mémoires de la Société Médicale des Hôpitaux de Paris|issue=3rd series|volume=13|pages=220–226|language=fr |id={{NAID|10014879958}} |oclc=493643386 }}</ref><ref name="AntoineBernardJean">{{cite web|title=Antoine Bernard-Jean Marfan|url=http://www.whonamedit.com/doctor.cfm/972.html|website=Whonamedit?|access-date=16 May 2016|url-status=live|archive-url=https://web.archive.org/web/20160308084456/http://www.whonamedit.com/doctor.cfm/972.html|archive-date=8 March 2016}}</ref>。

== 流行病学状况 ==
马凡氏症候群发病无性别倾向，其突变率亦无地域倾向。据估计在[[美国|美国]]大约有60,000（占人口数0.02%）到200,000人患有此病。该病致病基因携带者有一半的机率将其传给下一代。大多数马凡氏症候群患者有家族史，但同时又有15~30%的患者是由于自身突变导致的——这种自发突变率大约是2万分之一。马凡氏症候群也是一个[[显性负突变|显性负突变]]（dominant negative mutation）和[[单倍不足|单倍不足]]（haploinsufficiency）的疾病例子。其发病与[[可变表现度|可变表现度]]（variable expressivity）有关，但[[不完全外显率|不完全外显率]]（incomplete penetrance）还没有被正式确定。

==社會及文化==
研究顯示，[[古埃及|古埃及]][[埃及第十八王朝|第十八王朝]][[法老|法老]][[阿肯那顿|阿肯那顿]]很可能是馬凡氏症候群的患者<ref name="The Mystery of Akhenaten: Genetics or Aesthetics?">{{cite web|url=http://www.heptune.com/Marfans.html|title=The Mystery of Akhenaten: Genetics or Aesthetics?|3=|accessdate=2014-01-01|archive-date=2010-02-08|archive-url=https://web.archive.org/web/20100208110136/http://www.heptune.com/Marfans.html|dead-url=yes}}</ref><ref name="Akhenaten's illness">{{cite web|url=http://ancientegyptonline.co.uk/akhenaten.html|title=Akhenaten's illness|3=|accessdate=2014-01-01|archive-date=2014-01-26|archive-url=https://web.archive.org/web/20140126000536/http://ancientegyptonline.co.uk/akhenaten.html|dead-url=no}}</ref>。

另一位引起公眾對馬凡氏症候群關注的是[[1984年洛杉磯奧運會|1984年洛杉磯奧運會]][[1984年夏季奧林匹克運動會排球比賽#獎牌統計|女排銀牌得主]]美國隊的成員[[弗洛拉·海曼|弗洛拉·海曼]]（{{lang|en|Flora "Flo" Hyman}}），她在比賽時由於[[主動脈夾層|主動脈夾層]]剝離而突然死亡<ref name="flo">{{Cite web|url=http://www.volleyhall.org/hyman.html|archiveurl=https://web.archive.org/web/20080130003123/http://www.volleyhall.org/hyman.html|title=Flo Hyman|archivedate=2008-01-30|publisher=Volleyball Hall of Fame|accessdate=2009-01-06|language=en|deadurl=yes}}</ref>。

遺傳學家現時不再認為[[美國總統列表|美國前總統]][[阿伯拉罕·林肯|阿伯拉罕·林肯]]患有此病<ref>{{cite book |author=Marion R |chapter=Mr. Lincoln and Dr. Marfan's syndrome |title=Was George Washington Really the Father of Our Country? |publisher=Addison-Wesley |location=Reading, MA |year=1994}}</ref><ref>{{cite journal |author=Ready T |title=Access to presidential DNA denied |journal=Nature Medicine |volume=5 |pages=859 |year=1999 |pmid= 11645164 }}</ref><ref>{{cite book |author=Sotos JG |title=The Physical Lincoln Sourcebook |publisher=Mt. Vernon Book Systems |location=Mt. Vernon, VA |year=2008 |pages=29|isbn=978-0-9818193-3-4}}</ref>，他的異常身高很大可能是由於[[多發性內分泌腫瘤2B型|多發性內分泌腫瘤2B型]]（{{lang|en|Multiple endocrine neoplasia type 2B}}）引致<ref>{{cite book|title=The Physical Lincoln |last=Sotos |first=John G. |publisher= Mt. Vernon Book Systems |year=2008 |isbn=978-0-9818193-2-7}}</ref>。

近年又有身高207公分的[[烏克蘭|烏克蘭]]婦女琉德米拉（Lyudmila Titchenkova）<ref>{{cite news |url=http://www.ettoday.net/news/20130422/195642.htm#ixzz2nos8jqHj |title=烏克蘭17歲正妹207公分　姊妹合體超過一層樓 |date=2013-04-22 |publisher=[[ETtoday|ETtoday]]國際新聞 |language=Zh-hant |accessdate=2013-12-18 |archive-date=2019-12-04 |archive-url=https://web.archive.org/web/20191204161155/https://www.ettoday.net/news/20130422/195642.htm#ixzz2nos8jqHj |dead-url=no }}</ref>，因為高異常高度而引起大眾對這病的關注。

NBA2014年選秀會，來自貝勒大學的奧斯汀（Isaiah Austin）在選秀會幾天前，被診斷出罹患馬凡氏症候群，而被醫生禁止參與籃球相關活動，NBA主席席爾佛（Adam Silver），為了讓奧斯汀圓夢，特別在選秀會上宣布道：「2014年選秀會的下一個選秀順位，NBA聯盟將挑選…奧斯汀！」奧斯汀經過積極治療，他已經得到醫生的許可，並尋求再次挑戰NBA的機會。

==參見==
*[[Β受体阻滞剂|β受體阻滯劑]]（Beta blocker）
*[[血管紧张肽I转化酶抑制剂|血管紧张肽I转化酶抑制剂]]（ACE inhibitor）

==參考資料==
{{reflist|2}}

==參考文獻==
{{refbegin}}
* {{citation |title=Marfan syndrome |work=NIH's Office of Rare Diseases |url=http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&diseaseID=6975 |ref={{sfnRef|NIH}} |accessdate=2014-05-25 |archive-date=2012-10-19 |archive-url=https://web.archive.org/web/20121019172445/http://rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&DiseaseID=6975 |dead-url=no }}
* {{cite book |author=Dietz HC |chapter=Marfan Syndrome |chapterurl=http://www.ncbi.nlm.nih.gov/books/NBK1335/ |editor=Pagon RA, Bird TD, Dolan CR, ''et al.'' |title=GeneReviews™ [Internet] (1993–) |publisher=University of Washington, Seattle |location=Seattle WA |date=December 2011 |id=NBK1335 |pmid=20301510 |access-date=2014-05-25 |archive-date=2021-04-27 |archive-url=https://web.archive.org/web/20210427193711/https://www.ncbi.nlm.nih.gov/books/NBK1335/ |dead-url=no }}
* {{cite book |author=Greally MT |chapter=Shprintzen-Goldberg |chapterurl=http://www.ncbi.nlm.nih.gov/books// |editor=Pagon RA, Bird TD, Dolan CR, ''et al.'' |title=GeneReviews™ [Internet] (1993–) |publisher=University of Washington, Seattle |location=Seattle WA |date=November 2010 |id=NBK1277 |pmid=20301454 |ref={{harvid|Greally|GeneReviews|2010}} |access-date=2014-05-25 |archive-date=2021-05-30 |archive-url=https://web.archive.org/web/20210530084155/https://www.ncbi.nlm.nih.gov/books/ |dead-url=no }}
* {{cite journal |author=Dean JC |title=Marfan syndrome: clinical diagnosis and management |journal=Eur. J. Hum. Genet. |volume=15 |issue=7 |pages=724–33 |date=July 2007 |pmid=17487218 |doi=10.1038/sj.ejhg.5201851 |url=http://www.nature.com/ejhg/journal/v15/n7/full/5201851a.html |access-date=2014-05-25 |archive-date=2017-06-27 |archive-url=https://web.archive.org/web/20170627024304/http://www.nature.com/ejhg/journal/v15/n7/full/5201851a.html |dead-url=no }}
{{refend}}

==外部連結==
*[http://www.marfan.org.hk/ 香港馬凡氏綜合症協會] {{Wayback|url=http://www.marfan.org.hk/ |date=20210227063529 }}

{{系统性结缔组织疾病}}

{{Authority control}}
[[Category:症候群|Category:症候群]]
[[Category:人名疾病|Category:人名疾病]]
[[Category:结缔组织疾病|Category:结缔组织疾病]]
[[Category:常染色体显性遗传疾病|Category:常染色体显性遗传疾病]]
[[Category:真皮纤维与弹性组织异常情况|Category:真皮纤维与弹性组织异常情况]]
[[Category:筋膜障礙|Category:筋膜障礙]]
[[Category:心脏瓣膜疾病|Category:心脏瓣膜疾病]]
[[Category:细胞支架缺陷|Category:细胞支架缺陷]]
[[Category:全身性結締組織疾病|Category:全身性結締組織疾病]]
[[Category:罕見疾病症候群|Category:罕見疾病症候群]]
[[Category:膠原病|Category:膠原病]]
[[Category:影響神經系統的症狀|Category:影響神經系統的症狀]]